GPCR Valuation Metrics
FCF$-225.81M
FCF Growth Rate—
EPS Growth (CAGR)—
WACC10.00%
Structure Therapeutics Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Structure Therapeutics Inc
Current Price
$38.69
-2.89%Profile
Valuation (TTM)
Market Cap$2.74B
P/E-16.07
EV—
P/B1.81
Shares Out70.77M
P/Sales—
Revenue$0.00
EV/EBITDA—
Structure Therapeutics Inc (GPCR) Valuation
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →GPCR Valuation & Fair Value Analysis
Structure Therapeutics Inc (GPCR) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The price-to-earnings (P/E) ratio is -16.07. Price-to-book ratio is 1.81. PEG ratio is -0.54.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Structure Therapeutics Inc's intrinsic value.